1. N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum neutralization.
- Author
-
Lo VT, Lim HA, Jang SS, Kim MC, Chamfort AC, Kim HY, Mun DY, Kang MC, Lee HB, Kim S, Lee Y, Park S, Yoon SW, and Kim HK
- Subjects
- Animals, Humans, Mice, Amino Acid Substitution, Mutation, Spike Glycoprotein, Coronavirus genetics, Spike Glycoprotein, Coronavirus immunology, SARS-CoV-2 immunology, SARS-CoV-2 genetics, Antibodies, Neutralizing blood, Antibodies, Neutralizing immunology, Neutralization Tests, Antibodies, Viral blood, Antibodies, Viral immunology, COVID-19 immunology, COVID-19 virology
- Abstract
The N121 site on the spike protein of SARS-CoV-2 is associated with heme and its metabolite, biliverdin, which can affect antibody binding. Both N121T and N121S substitutions have been observed in natural conditions and in a hamster model of dual infection with SARS-CoV-2 and Influenza A virus. Serum pseudotype neutralization assays against HIV-1 particles carrying wild-type, N121T, and N121S spikes with immune mouse and human sera revealed that N121T and N121S mutations had a greater impact on serum neutralization than biliverdin treatment. Although N121T and N121S substitutions are not currently major SARS-CoV-2 variants of concern, this study could provide fundamental information to prepare for potential future mutations at the N121 site of SARS-CoV-2., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF